Physician profile
Roberto Pedraza
NPI 1053419614
$5,531.62
in general payments reported to CMS, 2019-2025
40 companies · $1,223 in 2025
The $1,223 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $118 · 2021: $607 · 2022: $544 · 2023: $1,005 · 2024: $1,556 · 2025: $1,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,749 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,748.50 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $683.95 | 2022-2025 | Urolift |
| Astellas Pharma US INC | $615.84 | 2019-2025 | Myrbetriq, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $481.12 | 2019-2025 | |
| Urogen Pharma, INC. | $439.63 | 2021-2025 | Jelmyto |
| Abbvie INC. | $437.08 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $353.53 | 2024-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $268.79 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Axonics, INC. | $214.74 | 2023-2024 | Axonics |
| Janssen Biotech, INC. | $191.23 | 2019-2025 | Erleada, Akeega |
| Progenics Pharmaceuticals, INC. | $187.83 | 2023-2025 | Pylarify |
| Antares Pharma, INC. | $172.72 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Immunitybio, INC. | $135.17 | 2025 | |
| Tolmar, INC. | $129.44 | 2023-2025 | Jatenzo, Eligard |
| Endo Pharmaceuticals INC. | $120.36 | 2019-2023 | Xiaflex, Edex, Aveed |
| Allergan, INC. | $109.86 | 2019-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Pedraza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.